Clinical Trial Update: Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating enzalutamide in combination with indomethacin for recurrent or metastatic hormone-resistant prostate cancer is listed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Mamta Parikh | Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN